Herbalife Nutrition Ltd vs Strategy Inc. — how do they compare? Herbalife Nutrition Ltd trades at $13.03 (market cap $1.34B), while Strategy Inc. trades at $154.6 (market cap $60.40B). The key difference: Strategy Inc. is far larger — about 45.1× Herbalife Nutrition Ltd's market cap, and Herbalife Nutrition Ltd is trading nearer its 52-week high, Strategy Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Herbalife Nutrition Ltd for 43 Days and Strategy Inc. for 112 Days on average.
| HLF | MSTR | |
|---|---|---|
Market Cap | $1.34B | $60.40B |
Volume | 1,589,457 | 23,421,830 |
Sector | Consumer Staples | Technology |
52-Week High | $19.96 | $320.29 |
52-Week Low | $7.75 | $82.31 |
Typical Hold Time | 43 Days | 112 Days |
Enterprise Value | $3.18B | $79.16B |
Signals from Pluang's Aura AI — not financial advice
Herbalife (HLF) trades at $13.03, up 3.0% with a bullish technical signal. The stock shows attractive valuation metrics with P/E of 8.22 and P/S of 0.26, while maintaining strong gross margins of 77.7%. Recent Q1 2026 earnings beat expectations, though Q2 2026 missed. The company announced a $250 million share repurchase program and CEO transition, with management reaffirming 2026 guidance. Cash flow trends show improvement with projected positive net cash flow of $50 million for 2026.
HLF presents a value opportunity with discounted valuation and improving debt profile, though execution risks remain. Analyst consensus targets $19.00 (53.8% upside) with 14 buy ratings. Key risks include mixed earnings performance, high debt levels despite recent reduction, and leadership transition. The stock offers potential for re-rating if management delivers on margin expansion and growth targets outlined in recent investor presentations.
MSTR stock trades at $154.34, up 0.63% with a bullish technical signal and strong analyst support. The company shows concerning fundamentals with negative net income margins of -6,102.96% and three consecutive earnings misses, though revenue remains stable around $477 million. Recent news highlights Citigroup's upgraded price target to $240 and the stock's 35% monthly surge, positioning it as a high-risk, high-reward play tied to Bitcoin market movements despite operational challenges.
Outlook remains polarized: 62% analyst buy ratings and a $253 consensus target suggest 64% upside, but extreme profitability risks and volatile cash flows demand caution. Investment opportunity hinges on Bitcoin's performance amplifying equity value, while risks include persistent losses, debt burden, and sensitivity to crypto market swings.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →